23 results on '"Salmon, Pierre Krolak"'
Search Results
2. Self‐reflection is associated with markers of Alzheimer's disease in cognitively unimpaired older adults.
3. White matter hyperintensities in the splenium of the corpus callosum predict cognitive decline in memory clinic outpatients.
4. Dementia with Lewy bodies: Characteristics of the prodromal stage in a nationwide longitudinal cohort: Neuropsychiatry and behavioral neurology: DLB and FTD — clinical manifestations.
5. Pathways involved in the relationship between resilience and cognitive function: The Memento cohort: Epidemiology: Lifestyle risk factors.
6. Dementia with Lewy bodies: Characteristics of the prodromal stage in a nationwide longitudinal cohort: Neuropsychiatry and behavioral neurology: DLB and FTD — clinical manifestations.
7. White matter hyperintensities across the adult life span: Links with age, amyloid load and cognition: Neuropsychology/Neuropsychological profiles of dementia: Valid biomarkers?
8. White matter hyperintensities across the adult life span: Links with age, amyloid load and cognition: Neuropsychology/Neuropsychological profiles of dementia: Valid biomarkers?
9. P1‐346: REGIONAL FRONTAL CORTEX VOLUME PREDICTS APATHY IN ALZHEIMER'S DISEASE.
10. O4‐07‐05: NIA‐AA RESEARCH FRAMEWORK: APPLICATION TO THE FRENCH POPULATION BY INFERENCE FROM THE MEMENTO COHORT.
11. F1‐04‐04: THE SCD‐WELL RANDOMIZED CONTROLLED TRIAL: EFFECTS OF A MINDFULNESS‐BASED INTERVENTION VERSUS HEALTH EDUCATION ON MENTAL HEALTH AND COGNITION IN PATIENTS WITH SUBJECTIVE COGNITIVE DECLINE.
12. P4‐086: PERSONALITY AND BEHAVIORAL AND PSYCHOLOGICAL SYMPTOMS OF DEMENTIA: RESULTS FROM THE PACO STUDY.
13. P1‐341: BRAIN VOLUME PREDICTS BEHAVIORAL AND PSYCHOLOGICAL SYMPTOMS IN ALZHEIMER'S DISEASE.
14. ADDED VALUE OF FLORBETABEN PET IMAGING ON DIAGNOSIS AND MANAGEMENT IN COMPLEX CASES OF PATIENTS WITH MILD DEMENTIA ELIGIBLE FOR CSF ANALYSIS IN THE FRENCH CLINICAL PRACTICE SETTING.
15. IS THE PROSPECTIVE ASSOCIATION BETWEEN DOMAIN-SPECIFIC COGNITIVE IMPAIRMENT AND INCIDENT DEMENTIA MODIFIED BY EDUCATION? THE MEMENTO COHORT.
16. SHORT-TERM PREDICTION OF CONVERSION FROM MILD COGNITIVE IMPAIRMENT TO DEMENTIA IN PATIENTS IN THE MEMENTO COHORT, 2011-2016.
17. APOE GENE MODIFIES THE LINK BETWEEN TYPE 2 DIABETES AND DEMENTIA RISK: THE MEMENTO COHORT.
18. DEFICITS IN VISUAL RECOGNITION MEMORY: A MARKER OF EARLY MESIAL TEMPORAL LOBE DEGENERATION IN NONDEMENTED OUTPATIENTS FROM MEMORY CLINICS?
19. PREVALENCE AND CHARACTERISTICS OF PATIENTS WITH ALZHEIMER’S DISEASE ELIGIBLE FOR A DISEASE MODIFYING DRUG (PANACEA).
20. ARE ALZHEIMER’S DISEASE RISK GENES RELATED TO MARKERS OF BRAIN PATHOLOGY? THE MEMENTO COHORT.
21. EXPLORING THE ANATOMICAL SUBSTRATE OF EPISODIC MEMORY: THE STRUCTURAL MRI CORRELATES OF THE FREE AND CUED SELECTIVE REMINDING TEST IN THE MEMENTO COHORT.
22. How could potential selection bias impact the analysis of correlates of cerebrospinal fluid biomarkers? the memento cohort.
23. Age differences in the association of white matter lesions with the occurrence of dementia: The memento cohort.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.